Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7NMU

Crystal structure of human platelet glycoprotein VI in complex with an inhibitory nanobody.

This is a non-PDB format compatible entry.
Summary for 7NMU
Entry DOI10.2210/pdb7nmu/pdb
DescriptorPlatelet glycoprotein VI, Nanobody 2, CALCIUM ION, ... (4 entities in total)
Functional Keywordsnanobody, complex, domain-swap, blood clotting
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains4
Total formula weight71123.59
Authors
Slater, A.,Jonas, E.,Watson, S.P. (deposition date: 2021-02-23, release date: 2021-03-10, Last modification date: 2024-11-13)
Primary citationSlater, A.,Di, Y.,Clark, J.C.,Jooss, N.J.,Martin, E.M.,Alenazy, F.,Thomas, M.R.,Ariens, R.A.S.,Herr, A.B.,Poulter, N.S.,Emsley, J.,Watson, S.P.
Structural characterization of a novel GPVI-nanobody complex reveals a biologically active domain-swapped GPVI dimer.
Blood, 137:3443-3453, 2021
Cited by
PubMed Abstract: Glycoprotein VI (GPVI) is the major signaling receptor for collagen on platelets. We have raised 54 nanobodies (Nb), grouped into 33 structural classes based on their complementary determining region 3 loops, against recombinant GPVI-Fc (dimeric GPVI) and have characterized their ability to bind recombinant GPVI, resting and activated platelets, and to inhibit platelet activation by collagen. Nbs from 6 different binding classes showed the strongest binding to recombinant GPVI-Fc, suggesting that there was not a single dominant class. The most potent 3, Nb2, 21, and 35, inhibited collagen-induced platelet aggregation with nanomolar half maximal inhibitory concentration (IC50) values and inhibited platelet aggregation under flow. The binding KD of the most potent Nb, Nb2, against recombinant monomeric and dimeric GPVI was 0.6 and 0.7 nM, respectively. The crystal structure of monomeric GPVI in complex with Nb2 revealed a binding epitope adjacent to the collagen-related peptide (CRP) binding groove within the D1 domain. In addition, a novel conformation of GPVI involving a domain swap between the D2 domains was observed. The domain swap is facilitated by the outward extension of the C-C' loop, which forms the domain swap hinge. The functional significance of this conformation was tested by truncating the hinge region so that the domain swap cannot occur. Nb2 was still able to displace collagen and CRP binding to the mutant, but signaling was abolished in a cell-based NFAT reporter assay. This demonstrates that the C-C' loop region is important for GPVI signaling but not ligand binding and suggests the domain-swapped structure may represent an active GPVI conformation.
PubMed: 33512486
DOI: 10.1182/blood.2020009440
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.5 Å)
Structure validation

246905

PDB entries from 2025-12-31

PDB statisticsPDBj update infoContact PDBjnumon